ArticleJournal of personalized medicine2025

Real-World Evidence on Low-Dose Olanzapine (≤1.25 mg) for Personalized Antipsychotic Dosing.

Danbee Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.